Found 639 matching trials
Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer PHASE4 Hyperkalemia (high potassium in blood) is a common condition found in kidne...
Show More Location
The Rogosin Institute
Learn More & Join Trial
The Differential Effects of 3 Different Immunosuppressive N/A The study is a laboratory investigation comparing the regulatory effects of...
Show More Location
Northwestern Memorial Hospital
Learn More & Join Trial
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD PHASE2 To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT a...
Show More Location
Wills Eye Institute
Learn More & Join Trial
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Rocky Mountain Cancer Centers
Learn More & Join Trial
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants PHASE4 The primary purpose of this study is to evaluate the pulse wave velocity an...
Show More Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus PHASE4 Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression PHASE2 Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Show More Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders PHASE2 RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
COVID Protection After Transplant-Immunosuppression Reduction PHASE2 This study will enroll individuals who have:
* Completed primary series of...
Show More Location
University of California, San Diego
Learn More & Join Trial